A multicentre, non-interventional, prospective observational study of the use of the sufentanil sublingual tablet system (Zalviso®) for the management of acute postoperative pain in a hospital setting (ZAS)

26/01/2017
01/04/2024
EU PAS number:
EUPAS16829
Study
Finalised
Documents
Study protocol
Study results
Study results
English (140.92 KB - PDF) View document
Study report
Other information